Why Did Tonix Pharmaceuticals Holding Corp. (TNXP) Soar 16.88%?

On May 16, 2025, Tonix Pharmaceuticals Holding Corp. (TNXP) surged 16.88% in pre-market trading, marking a significant rise in its stock price.

Tonix Pharmaceuticals Holding Corp. (TNXP) experienced a notable increase in its stock price on Wednesday, driven by the appointment of Joseph Hand as the company's General Counsel. This strategic move has garnered positive attention from retail investors, contributing to the stock's upward trajectory.

Joseph Hand, a former executive at Celgene Corp., brings a wealth of experience to Tonix, which has been instrumental in boosting investor confidence. His appointment is seen as a strategic enhancement for the company, potentially leading to further growth and development in the pharmaceutical sector.